Press release
-
Press Release
Impac Mortgage Holdings, Inc. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Impac Mortgage Holdings, Inc. cybersecurity incident NEWPORT…
Read More » -
Press Release
Kemper Corporation Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Kemper Corporation cybersecurity incident NEWTOWN, Pa., April…
Read More » -
Press Release
Kemper Corporation Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Kemper Corporation cybersecurity incident NEWTOWN, Pa., April…
Read More » -
Press Release
Georgia Heritage Financial Credit Union Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Georgia Heritage Financial Credit Union cybersecurity incident…
Read More » -
Press Release
Ampace Spotlights AI-Ready Battery Solutions for Gigascale Infrastructure at DCW Washington 2026
WASHINGTON, April 21, 2026 /PRNewswire/ — Ampace, a global leader in advanced lithium-ion battery technology, is participating in Data Center World…
Read More » -
Press Release
Georgia Heritage Financial Credit Union Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information
National class action firm offering free case evaluations to individuals impacted by the Georgia Heritage Financial Credit Union cybersecurity incident…
Read More » -
Dayspring Pharma Announces Phase II Trial of CG2001 Foam Met Primary Endpoint in Chinese Adult Men with AGA
BEIJING, April 21, 2026 /PRNewswire/ — Dayspring Pharma today announced top-line data from its Phase II clinical trial of CG2001 foam…
Read More » -
Ractigen Therapeutics Presents Positive Phase I Data for RAG-17 in SOD1-ALS at the 2026 AAN Annual Meeting, Demonstrating 81% Reduction in Neurofilament Light Chain
— Single intrathecal dose of SCAD-siRNA therapeutic RAG-17 yields favorable safety profile and profound, durable biomarker reductions —— Preliminary data…
Read More » -
Case Report of Mabwell’s Nectin-4 targeting ADC (9MW2821) in Cervical Cancer Published in The New England Journal of Medicine
SHANGHAI, April 21, 2026 /PRNewswire/ — Mabwell (688062.SH), an innovation-driven biopharmaceutical company with a fully integrated industrial chain, announced that…
Read More » -
Press Release
Nektar Therapeutics Announces Pricing of Upsized $325 Million Public Offering
SAN FRANCISCO, April 21, 2026 /PRNewswire/ — Nektar Therapeutics (Nasdaq: NKTR), a clinical-stage biotechnology company focused on the development of innovative…
Read More »






